Dr. Lal PathLabs Ltd
Ticker: LALPATHLAB
Decent
48/100
☆ Add to Watchlist
Investing Reference
Price
3135.50
Market Cap
26171.11
Debt/Equity
0.0713
ROE %
23.810
PB
11.8611
Promoter %
53.215
Pledge %
0.000
1Y Rev Growth %
11.282
5Y Rev Growth %
13.020
NP Margin %
19.067
NP Margin 5Y Avg %
16.046
Trading Reference
1M Return %
-0.981
6M Return %
12.239
1Y Return %
0.723
% Away 52W High
12.901
% Away 52W Low
36.709
Daily Volume
528369
Investment Verdict
Hold
Score 64/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 40/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
Dr. Lal PathLabs Ltd shows strong growth potential in the diagnostic sector, driven by expanding services and a robust brand presence.
✅ Positives
- Strong market position in diagnostics
- Consistent revenue growth year-on-year
- Expanding network of collection centers
⚠️ Negatives
- High competition in the healthcare sector
- Regulatory challenges may arise
- Rising operational costs impacting margins
Verdict
Moderate growth potential with some risks.
Recommendation: Consider buying on dips.
Upside Probability: 25% | Downside Probability: 15%
Last generated: 30/10/2025
More Options
S
Sumitomo Chemical India Ltd
Sumitomo Chemical India Ltd shows potential for growth, but faces challenges in profitability and execution risks.
View details
A
Aegis Vopak Terminals Ltd
Aegis Vopak Terminals Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should be cautious.
View details
H
Hindustan Copper Ltd
Hindustan Copper Ltd shows potential but faces significant challenges in growth and profitability, making it a risky investment at this time.
View details
T
TVS Holdings Ltd
TVS Holdings Ltd shows potential for growth, particularly in the electric vehicle segment, but faces challenges in profitability and valuation metrics.
View details
A
Amber Enterprises India Ltd
Amber Enterprises shows potential for growth in a favorable sector, but faces valuation concerns and execution risks.
View details
S
Syngene International Ltd
Syngene International Ltd shows a decent investment profile with consistent growth and profitability metrics, though valuation is slightly elevated.
View details
S
Sona BLW Precision Forgings Ltd
Sona BLW Precision Forgings Ltd shows promise in a growing sector, but faces challenges in profitability and valuation metrics.
View details
J
J B Chemicals and Pharmaceuticals Ltd
J B Chemicals and Pharmaceuticals Ltd shows decent potential with a stable growth outlook, but investors should be cautious of execution risks and valuation metrics.
View details
B
Bandhan Bank Ltd
Bandhan Bank Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Investors should be cautious.
View details
P
Piramal Pharma Ltd
Piramal Pharma Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
E
Emami Ltd
Emami Ltd shows potential in the FMCG sector with decent growth prospects, but faces challenges in profitability and execution risks.
View details
S
Star Health and Allied Insurance Company Ltd
Star Health and Allied Insurance Company Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
I
IRB Infrastructure Developers Ltd
IRB Infrastructure Developers Ltd shows potential in a growing sector, but faces challenges in execution and valuation.
View details
I
Inventurus Knowledge Solutions Ltd
The stock presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns. Caution is advised for potential investors.
View details
I
Inox Wind Ltd
Inox Wind Ltd faces several challenges, including inconsistent growth and market competition, making it a risky investment at this time.
View details
N
National Securities Depository Ltd
National Securities Depository Ltd shows decent fundamentals with stable growth prospects, but faces some execution risks and competition.
View details
Business Overview
Dr. Lal PathLabs Ltd is a leading diagnostic and healthcare service provider in India, offering a wide range of pathology tests and health check-up packages. Catering to both individual patients and healthcare institutions, the company is committed to delivering accurate results with quick turnaround times. With a strong network of laboratories and collection centers, it ensures accessibility and convenience for all. Dr. Lal PathLabs is dedicated to maintaining high-quality standards and employs advanced technology to enhance patient care.
- Leading diagnostic service provider in India
- Wide range of pathology tests and health check-ups
- Accessible with a strong network of labs
- Commitment to accuracy and quick results
- Advanced technology for enhanced patient care
- Trusted by individuals and healthcare institutions
Investment Thesis
Dr. Lal PathLabs Ltd stands out as a solid investment due to its credible promoter group, robust growth in digital services, and attractive valuation compared to peers. These factors position the company for sustained growth in the expanding healthcare sector.
- Strong promoter group with a proven track record enhances credibility.
- Significant growth potential in digital services catering to tech-savvy consumers.
- Attractive valuation metrics compared to industry peers, offering a compelling entry point.
- Established brand presence and trust in diagnostics ensure customer loyalty.
- Strategic expansion plans align with the increasing demand for healthcare services.
Opportunity vs Risk
Opportunities
- Growing demand for diagnostic services
- Expansion into tier 2 and 3 cities
- Strong brand recognition in healthcare
- Technological advancements in testing
- Partnerships with hospitals and clinics
Risks ⚠️
- Intense competition in diagnostics sector
- Regulatory changes affecting operations
- Economic slowdown impacting consumer spending
- Dependence on skilled labor
- Potential data privacy concerns
Peer Perspective
Dr. Lal PathLabs Ltd trades at a premium compared to peers like Thyrocare and Metropolis, reflecting its strong growth potential. A sustained focus on margin stability could trigger a rerating in its valuation.
Future Outlook
Dr. Lal PathLabs Ltd is well-positioned for growth, driven by expanding healthcare demands. However, successful execution of operational efficiencies and cost control will be crucial to fully capitalize on these opportunities.
AI FAQs for Retail Users
- Q: What does Dr. Lal PathLabs do?A: Dr. Lal PathLabs is a leading diagnostic and pathology service provider in India.
- Q: Is Dr. Lal PathLabs a profitable company?A: Yes, Dr. Lal PathLabs has shown consistent profitability over the years.
- Q: What factors affect Dr. Lal PathLabs' stock price?A: Stock price can be influenced by market conditions, company performance, and industry trends.
- Q: How can I invest in Dr. Lal PathLabs?A: You can invest through a stockbroker or an online trading platform.
- Q: What are the risks of investing in Dr. Lal PathLabs?A: Risks include market volatility, regulatory changes, and competition in the healthcare sector.
📊 Stock Investment Checklist (100 Points)
Dr. Lal PathLabs Ltd • Updated: 2025-09-16 20:32:45
-
10BusinessHighThe healthcare sector is growing, but competition is increasing.
-
10GrowthHighConsistent revenue growth, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but cash flow is inconsistent.
-
8ValuationHighValuation metrics are higher than peers, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity could be improved.
-
9GovernanceHighPromoter holding is strong, but there are some concerns about disclosures.
-
10DriversHighGrowth drivers exist, but execution risks are notable.
-
5TechnicalsGoodMarket sentiment is mixed, with low liquidity.
Final Score & Verdict
Score 48 / 100
• Decent
Dr. Lal PathLabs Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 80/100
- Governance: 65/100
- Market Confidence: 72/100